Safety and Efficacy of Encoberminogene Rezmadenovec
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
EXACT Trial: Results of the Phase 1 Dose-Escalation Study
Circ Cardiovasc Interv 2023 Jul 28;[EPub Ahead of Print], TJ Povsic, TD Henry, JH Traverse, RD Anderson, GA Answini, BC Sun, GJ Arnaoutakis, KD Boudoulas, AR Williams, HC Dittrich, EA Tarka, DA Latter, EM Ohman, MW Peterson, D Byrnes, CJ Pepine, MF DiCarli, RG Crystal, TK Rosengart, NA MokadamFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.